REQUEST A DEMO
Total
USD $0.00
Search more companies

Renocare Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Renocare Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Renocare Pharmaceuticals Private Limited is an unlisted company, incorporated on 26/06/2009. It has its registered office in the State of Tamil Nadu, India. Company's corporate identification number (CIN) is U24230TN2009PTC072103 and registration number is 072103.

Legal Address
Plat No.Rf-6, I Floor,Abhi-Ani Terrace, Plot No.22,Gangai Amman Koil Iv Street,Vadapalani
Chennai; Tamil Nadu; Postal Code: 600026

Contact Details: Purchase the Renocare Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Renocare Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Renocare Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Renocare Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
June 26, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Renocare Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
14.03%
Total operating revenue
14.23%
Operating profit (EBIT)
-28.44%
EBITDA
-19.16%
Net Profit (Loss) for the Period
-25.49%
Total assets
23.16%
Total equity
65.14%
Operating Profit Margin (ROS)
-5.43%
Net Profit Margin
-3.77%
Return on Equity (ROE)
-91.68%
Debt to Equity Ratio
-71.21%
Quick Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?